Home › Macular Degeneration › Michigan › Ann Arbor
Macular Degeneration clinical trials in Ann Arbor, MI
4 studies for Macular Degeneration are looking for participants at sites in and around Ann Arbor (within about 30 miles). Open a study to see who can join and how to contact the study team.
Study to Evaluate Efficacy and Safety of ONL1204 in Patients With GA Associated With AMD
RecruitingPhase 2
- University of Michigan Kellogg Eye Center, Ann Arbor
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RecruitingPhase 1
- University of Michigan Kellog Eye Center, Ann Arbor
A Study to Learn How Stargardt-type Eye Conditions Progress in Children and Adults
RecruitingObservational study
- University of Michigan Health - Kellogg Eye Center, Ann Arbor
Feasibility and Safety of MB-102 in Ocular Angiography as Compared to Fluorescein Sodium
RecruitingEarly phase 1Healthy volunteers welcome
- University of Michigan Kellogg Eye Center, Ann Arbor
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Hagerstown, MD8 studies
- Reno, NV8 studies
- Sacramento, CA8 studies
- Santa Monica, CA7 studies
- Fort Worth, TX7 studies
- Houston, TX7 studies
- Austin, TX7 studies
- Carmel, IN7 studies
- Cleveland, OH7 studies
Other studies in Ann Arbor
- Prostate Cancer27 studies
- Cancer (all types)26 studies
- Breast Cancer26 studies
- Non-Small Cell Lung Cancer26 studies
- Lung Cancer23 studies
- Colorectal Cancer23 studies
- Heart Failure22 studies
- Acute Myeloid Leukemia17 studies
- Cardiovascular Disease16 studies
- Pancreatic Cancer14 studies
- Melanoma12 studies
- Kidney Cancer (Renal Cell Carcinoma)12 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.